Table 7.

Summary of review findings

Bladder cancer population	Best performing PROM using COSMIN	Further information	Alternatives	Further information
All (or a variety of stages/grades)	BCI	Suggested that BCI is used alongside generic and/or cancer‐generic PROMs as interpretation can be difficult	FACT‐Bl	FACT‐Bl can be used to collect BC‐specific and cancer‐generic HRQL information, as the PROM includes FACT‐G
MIBC	FACT‐VCI	FACT‐VCI can be used to collect BC‐specific and cancer‐generic HRQL information, as the PROM includes FACT‐G FACT‐VCI is only suitable to use with MIBC patients who have had a cystectomy	EORTC QLQ‐BLM30	EORTC QLQ‐BLM30 can be used to collect BC‐specific and cancer‐generic HRQL information, as the PROM can be used with EORTC QLQ‐C30 EORTC QLQ‐BLM30 is suitable to use with both cystectomy and conservative treatment patients
			IONB‐PRO	IONB‐PRO is only suitable to use with patients who have a neobladder
NMIBC	Difficult to determine as CAVICAVENMI only evaluated in one study and both EORTC QLQ‐NMIBC24 and CAVICAVENMI scored well	EORTC QLQ‐NMIBC24 can be used to collect BC‐specific and cancer‐generic HRQL information, as the PROM can be used with EORTC QLQ‐C30	CAVICAVENMI	CAVICAVENMI incorporates both BC‐specific and cancer‐generic questions within fewer items than the combination of EORTC QLQ‐C30 and EORTC QLQ‐NMIBC24